Patent EP0177991A2 successfully refreshed from Google Patents.
Patent US4144332A successfully refreshed from Google Patents.
US4144332A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for alleviating proliferative skin diseases
Assignee: University of Michigan (System)
•
Filing: 1977-06-21
•
Granted: 1979-03-13
•
Expires: 1997-06-21
Abstract
Abstract A process for alleviating proliferative skin diseases such as psoriasis, atopic dermatitis, etc. comprising administering to humans, or domesticated animals, topically and/or systemically a composition comprising a pharmaceutical carrier and at least one active compound selected from certain anilino nicotinic acids used alone, or in mixtures, or in combination with a glucocorticoid.
Inventors
- 👤 John J. Voorhees
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 15:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/54; A61K31/435; A61K31/44; A61K31/455; A61K31/495; A61K31/505; A61K31/519; A61K31/52; A61K31/56; A61K31/57
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
143 words
A process for alleviating proliferative skin diseases which comprises administering to the afflicted human or animal a composition containing as its active component at least one of the compounds selected from the group represented by the formula: ##STR22## where R is hydrogen or --CH 2 CHOHCH 2 OH, X is lower alkyl of from 1 to 8 carbon atoms, lower alkoxy of from 1 to 8 carbon atoms, chloro, bromo or NO 2 , Y is chloro, bromo, NO 2 or lower alkyl of from 1 to 8 carbon atoms, Z is hydrogen, halogen, CF 3 or lower alkyl of from 1 to 8 carbon atoms inclusive; said compound being in association with a pharmaceutical carrier wherein said active component is present in an amount in the range of about 0.1 to about 15% w/v which is effective to alleviate proliferative skin disease.
Claim 2
Dependent Claim
143 words
A process for alleviating proliferative skin diseases which comprises administering to the afflicted human or animal a composition containing as its active component at least one of the compounds selected from the group represented by the formula: ##STR22## where R is hydrogen or --CH 2 CHOHCH 2 OH, X is lower alkyl of from 1 to 8 carbon atoms, lower alkoxy of from 1 to 8 carbon atoms, chloro, bromo or NO 2 , Y is chloro, bromo, NO 2 or lower alkyl of from 1 to 8 carbon atoms, Z is hydrogen, halogen, CF 3 or lower alkyl of from 1 to 8 carbon atoms inclusive; said compound being in association with a pharmaceutical carrier wherein said active component is present in an amount in the range of about 0.1 to about 15% w/v which is effective to alleviate proliferative skin disease.
Claim 3
Dependent Claim
22 words
A process in accordance with claim 1 wherein said active component was administered in conjunction with a permissive dosage of a glucocorticoid.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-03-12 | 1982-09-11 | 1983-03-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-03-12 | 1986-09-11 | 1987-03-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-03-12 | 1990-09-11 | 1991-03-13 | $7700.00 | Window Closed / Lapsed |